Invention Grant
- Patent Title: EZH2 inhibitors for treating lymphoma
-
Application No.: US17526307Application Date: 2021-11-15
-
Publication No.: US11951109B2Publication Date: 2024-04-09
- Inventor: Heike Keilhack , Sarah Kathleen Knutson , Danielle Johnston Blackwell
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Dechert LLP
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/4412 ; A61K31/444 ; A61K31/475 ; A61K31/573 ; A61K31/675 ; A61K31/704 ; A61K39/395 ; A61K45/06 ; A61P35/00 ; G01N33/574
Abstract:
The present disclosure relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Public/Granted literature
- US20220175789A1 EZH2 INHIBITORS FOR TREATING LYMPHOMA Public/Granted day:2022-06-09
Information query
IPC分类:
